Health Canada inspection
Suzhou Novartis Pharma Technology Co., Ltd.: Health Canada inspection of Oct 18, 2018
Health Canada · GMP · rating C
Key facts
| Establishment | Suzhou Novartis Pharma Technology Co., Ltd. |
|---|---|
| City | Changshu |
| Province | Jiangsu |
| Country | China |
| Program | GMP |
| Start date | Oct 15, 2018 |
| End date | Oct 18, 2018 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.